Skip to main content
. Author manuscript; available in PMC: 2015 May 1.
Published in final edited form as: Am J Transplant. 2014 Apr 2;14(5):1084–1095. doi: 10.1111/ajt.12673

Figure 1.

Figure 1

Cumulative survival time of ex vivo perfused lungs. Lung “survival time” represents the time of perfusion at which a lung failure endpoint was met, based on the pre-defined criteria. Lung survival was significantly prolonged in GalTKO.hCD46 lungs compared to wild type (p < 0.001) but not compared to GalTKO lungs (p = 0.27). Autologously perfused lungs survived significantly longer than GalTKO.hCD46 transgenic lungs (+ p = 0.04).